Over-Expression of Egfr is Closely Correlated to Poor Prognosis in Tunisian Patients with Non-Small Cell Lung Adenocarcinoma

By              

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 256-268

Taylor & Francis Ltd

Access to resources Recommend Favorite

Small RNAs and Non-Small Cell Lung Cancer

By  

Current Molecular Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 339-349

Bentham Science Publishers

Access to resources Recommend Favorite

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 3, 2015-06 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC)

By Bellezza Guido   Sordo Rachele   Colella Renato   Ludovini Vienna   Ragusa Mark   Bianconi Fortunato   Ferri Ivana   Borri Filippo   Chiari Rita   Puma Francesco   Crinò Lucio   Sidoni Angelo  

Virchows Archiv, Vol. 463, Iss. 5, 2013-11 ,pp. : 663-671

Springer Publishing Company

Access to resources Recommend Favorite

PD1 gene promoter polymorphisms correlate with a poor prognosis in nonsmall cell lung cancer

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1035-1042

Spandidos Publications

Access to resources Recommend Favorite